Stay updated on AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Sign up to get notified when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.

Latest updates to the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page
- Check2 days agoChange DetectedRevision note updated to v3.3.4 and v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoChange DetectedTwo new sites were added to the study locations: Medical Oncology Associates in Spokane, WA, and Mid-Florida Hematology & Oncology Centers in Orange City, FL. The total number of locations increased to 18 (from 16).SummaryDifference0.4%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedLocations are now presented under a single Locations section with state-specific sites; the HHS Vulnerability Disclosure link was removed and the revision updated to v3.3.3.SummaryDifference0.9%

- Check45 days agoChange DetectedTwo new update timestamps were added to the study record (2025-11-26 and 2025-12-01) and earlier dates were removed; no changes to study design, eligibility, or locations.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page footer revision information was updated from v3.2.0 to v3.3.2, with no changes to the study details, inclusion/exclusion criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedThe government funding lapse notice that used to appear on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.